Appendix D

Biographical Sketches of Committee Members

Georges C. Benjamin, M.D. (Cochair), is a well-known health policy leader, practitioner, and administrator. He serves as the executive director of the American Public Health Association (APHA), the nation’s oldest and largest organization of public health professionals, where he is the publisher for American Journal of Public Health, The Nation’s Health newspaper, and APHA Press, its book company. Dr. Benjamin has published several articles on public health ethics, COVID-19, and health equity and is nationally known for his contributions. He is board certified in internal medicine, a master of the American College of Physicians, fellow of the National Academy of Public Administration, and fellow emeritus of the American College of Emergency Physicians. He serves on several nonprofit boards, such as Research!America, the Environmental Defense Fundand Ceres. Dr. Benjamin is a former secretary of health for the state of Maryland and former member of the National Infrastructure Advisory Council, which advises the president on how best to assure the security of the nation’s critical infrastructure. He is a graduate of the Illinois Institute of Technology and received his M.D. at the University of Illinois College of Medicine. Dr. Benjamin has chaired or cochaired several National Academies of Sciences, Engineering, and Medicine (National Academies) convening activities and was the chair of its division committee for the Health and Medicine Division (HMD). He is a member of the National Academy of Medicine (NAM).

Jennifer E. DeVoe, M.D., DPhil (Cochair), is a practicing family physician and health services researcher based in Portland, Oregon. She is the John and Sherrie Saultz Professor and Chair of the Department of Family Medicine at Oregon Health & Science University (OHSU). In her role as chair, she oversees nearly 250 faculty, 100 resident physicians, and several large primary care clinics. Dr. DeVoe also serves as the inaugural director of OSHU’s Center for Primary Care Research and Innovation and is the co-principal investigator of the Building Research in Implementation & Dissemination to Close Gaps and Achieve Equity in Cancer Control Center. She and her team were early pioneers in leveraging electronic health records in health disparities research. Her research evaluates natural experiments that impact access to primary care and community-based interventions that aim to reduce health disparities. Dr. DeVoe earned her M.Phil. and D.Phil. in economic and social history from Oxford University and her M.D. from Harvard Medical School. She completed her family medicine residency at OHSU. Dr. DeVoe chaired the 2018–2019 National Academies Committee on Vibrant and Healthy Kids: Aligning Science, Practice, and Policy to Advance Health Equity and served as a member of the 2020–2021 Committee on Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. She is a member of NAM.

Margarita Alegría, Ph.D., is the chief of the Disparities Research Unit at Massachusetts General Hospital, Harry G. Lehnert, Jr. and Lucille F. Cyr Lehnert Endowed Chair at the Mass General Research Institute, and professor in the Departments of Medicine and Psychiatry at Harvard Medical School. She was the director of the Center for Multicultural Mental Health Research at Cambridge Health Alliance (2002–2015). Dr. Alegria has published several articles on improving health care services delivery for diverse racial and ethnic populations. Her research focuses on improvement of health care services delivery for diverse racial and ethnic populations, conceptual and methodological issues with multicultural populations, and ways to bring a community perspective into designing and implementing health services. She is the principal investigator of three research studies funded by the National Institutes of Health. She has funding from groups such as the Robert Wood Johnson Foundation for conducting A Learning Assessment to Advance Racial Equity in the Health Sciences and Bank of America to partner with community organizations to test behavioral health interventions. Dr. Alegria was recently a member of the Robert Wood Johnson Foundation National Commission to Transform Public Health Data. She received the 2020 Rema Lapouse Award for Achievement in Epidemiology, Mental Health, and Applied Public Health Statistics from the APHA. She obtained her B.A. in psychology from Georgetown University and her Ph.D. from Temple University. Dr. Alegria is cochair of the National

Academies Forum on Mental Health and Substance Use Disorders and a member of the Division Committee for the Behavioral and Social Sciences and Education and NAM. She served as a member of the Committee on the Mental Health Workforce for Geriatric Populations and Committee on Standardized Collection of Race–Ethnicity Data for Healthcare Quality Improvement.

John Zaven Ayanian, M.D., M.P.P., is the Alice Hamilton Distinguished University Professor of Medicine and Healthcare Policy and director of the Institute for Healthcare Policy and Innovation at the University of Michigan. His research focuses on access to care, quality of care, and health equity. He leads a multidisciplinary team conducting the federally authorized evaluation of the Healthy Michigan Plan, which has expanded Medicaid to one million adults. Dr. Ayanian has published extensively on health and health care disparities. He is the founding editor in chief of JAMA Health Forum, a member of American Society for Clinical Investigation and Association of American Physicians, and a master of the American College of Physicians. He received the John Eisenberg National Award for Career Achievement in Research from the Society of General Internal Medicine and Distinguished Investigator Award from AcademyHealth. He earned his B.A. in history and political science from Duke University, M.D. from Harvard Medical School, and M.P.P. from the Harvard Kennedy School. He completed residency and fellowship training in primary care internal medicine at Brigham and Women’s Hospital and a postdoctoral fellowship in health services research at the Harvard School of Public Health. Dr. Ayanian has been a member of numerous National Academies committees, including on Consequences of Uninsurance, Accounting for Socioeconomic Status in Medicare Payment Programs, A National Surveillance System for Cardiovascular and Select Chronic Diseases, and Guidance for Designing a National Health Care Disparities Report. He is a member of NAM.

Elaine E. Batchlor, M.D., M.P.H., is the chief executive officer of MLK Community Healthcare, a state-of-the-art, CMS 5-star-rated hospital and health system that provides care to 1.3 million residents of the medically underserved community of South Los Angeles. In this role, and in her previous position as chief medical officer for LA Care, the nation’s largest public insurance plan, Dr. Batchlor has devoted her career to reducing health disparities and expanding health care quality and access for the most vulnerable communities. Her firsthand observations of the people, policy, and payment challenges to health equity have been widely published, including in Health Affairs, The Atlantic, The Washington Post, and The Los Angeles Times. Her innovative efforts to address provider shortages, payment inequities, and other structural and environmental obstacles to health earned

her the James Irvine Foundation Leadership Award, and the Partners in Care Vision and Excellence in Healthcare Leadership Award. An internist and rheumatologist by training, Dr. Batchlor received her M.D. from Case Western Reserve University School of Medicine and M.P.H. from UCLA Fielding School of Public Health. She is a member of NAM.

Darrell J. Gaskin, Ph.D., M.S., is the William C. and Nancy F. Richardson Professor in Health Policy and director of the Hopkins Center for Health Disparities Solutions in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Dr. Gaskin is a health services researcher and health economist and has published extensively on health and health care disparities. He is internationally recognized for his contribution. He seeks to identify and understand how contextual factors influence access to care, quality of care, and health outcomes for minority, low socioeconomic status, and other vulnerable populations and to develop and promulgate policies and practices that address the social determinants of health (SDOH) and promote equity in health and well-being. He is a research associate of the National Bureau of Economic Research. He is on the Congressional Budget Office Panel of Health Advisors and board of directors of the American Society of Health Economists. Dr. Gaskin has served in leadership roles in AcademyHealth, the APHA, the National Academy for State Health Policy, and the National Economics Association. He is a member of the Maryland Department of Health’s Advisory Committee on Minority Health, Maryland Health Equity Policy Committee, Health Affairs’ Health Equity Advisory Committee, and National Institute of Neurological Disorders and Stroke Health Disparities Steering Committee. He is a 2019 recipient of the Presidential Early Career Award for Scientists and Engineers. Dr. Gaskin has a Ph.D. in public health economics from Johns Hopkins University, an M.S. in economics from the Massachusetts Institute of Technology, and a B.A. in economics from Brandeis University. He has been a member of numerous National Academies committees, including on Rising Midlife Mortality Rates and Socioeconomic Disparities and on Valuing Community-Based, Non-Clinical Prevention Policies and Wellness Strategies. He is a member of NAM.

Vincent Guilamo-Ramos, Ph.D., M.S.N., M.P.H., FAAN, is the executive director of the Institute for Policy Solutions and distinguished professor at the Johns Hopkins School of Nursing. He was dean and Distinguished Professor of the Duke University School of Nursing, Vice Chancellor for Nursing Affairs director of the Center for Latino Adolescent and Family Health. Dr. Guilamo-Ramos is a nurse practitioner dually licensed in primary care and psychiatric-mental health nursing. His research focuses on

improving health care access, quality, and outcomes for Latino/a people and other populations experiencing structural adversity, with a focus on mitigating the mechanisms through which SDOH shape health inequities. His research has been federally funded for more than 2 decades by NIH and various other agencies. He has published more 100 manuscripts in leading peer-reviewed scientific and health journals, and his work has received national media attention in outlets such as the New York Times, The Guardian, and Newsweek. He serves as a member of the HHS Presidential Advisory Council on HIV/AIDS, HHS Panel on Antiretroviral Guidelines for Adults and Adolescents, CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, Board of UnidosUS, and National Academies Standing Committee on Reproductive Health, Equity, and Society and was recently on the National Academies Committee on Prevention and Control of STIs in the United States. Dr. Guilamo-Ramos received a Ph.D. in social welfare from SUNY Albany, an M.S.N. from Duke University, and an M.P.H., M.S.W., and M.S. from New York University.

Valarie Blue Bird Jernigan, Dr.P.H., M.P.H., is professor of rural health and medicine and director of the Center for Indigenous Health Research and Policy at Oklahoma State University Center for Health Sciences. Dr. Jernigan has been the principal investigator for more than a dozen research studies focusing on improving Indigenous food environments through policy and systems interventions. She also directs the Center for Indigenous Innovation and Health Equity, an academic–community partnership with American Indian, Alaska Native, Native Hawaiian, and Pacific Islander people to restore traditional foods and food practices to promote healthy diets and reduce chronic disease. In 2011, she was the inaugural chair of the National Cancer Institute’s Intervention Research to Improve Native Health initiative, a collaboration of NIH-funded investigators conducting intervention science research. Dr. Jernigan is a member of the Canadian Institutes of Health Research College of Reviewers, APHA, Society for Public Health Educators, and Society for Prevention Research. She is an editorial board member for the scientific journals Health Promotion Practice and Progress in Community Health Partnerships. Dr. Jernigan is a member of the CDC Fries Prize Award Jury, 2025 Dietary Guidelines for Americans Advisory Committee, and Advisory Council for the National Institute on Minority Health and Health Disparities. She received her Dr.P.H. from the University of California, Berkeley, and completed a postdoctoral fellowship in cardiovascular disease risk reduction at the Stanford Prevention Research Center, Stanford School of Medicine. Dr. Jernigan was a member of the National Academies workshop planning committee on Health Equity Approach to Obesity Efforts. She is an enrolled citizen of the Choctaw Nation of Oklahoma.

Thomas A. LaVeist, Ph.D., is the dean and Weatherhead Presidential Chair in Health Equity at the School of Public Health & Tropical Medicine at Tulane University. His career has been dedicated to understanding the causes of inequity in health and its potential solutions. He is a compensated member of the AstraZeneca Health Equity Advisory Council. He also serves as a judge for the Johnson & Johnson Health Equity Innovation Challenge. Dr. LaVeist is the director and executive producer of The Skin You’re In, a documentary series that discusses racial health inequities. He is also author of six books, including Minority Population and Health: An Introduction to Health Disparities in the United States (the first textbook on health disparities). As a research scientist, Dr. LaVeist has received the Innovation Award from the National Institutes of Health and Knowledge Award from the U.S. Department of Health and Human Services. He received his B.A. in sociology from the University of Maryland Eastern Shore, M.A. in sociology from the University of Michigan, and Ph.D. in medical sociology from the University of Michigan. He is a member of NAM.

Monica E. Peek, M.D., M.P.H., M.Sc., is the Ellen H. Block Professor of Health Justice at the University of Chicago, associate vice-chair for research faculty development at the University of Chicago Department of Medicine, executive medical director of community health innovations, associate director of the Chicago Center for Diabetes Translation Research, and director of research/associate director of the MacLean Center for Clinical Medical Ethics. She is a health services researcher, bioethicist, and internist focused on health equity. Dr. Peek’s research focuses on promoting equitable doctor–patient relationships among racial minorities, integrating medical and social needs, and addressing discrimination and structural racism that impact health outcomes. She receives funding from the Merck Foundation for work on health equity and diabetes. She has published extensively on SDOH, health disparities, and health care education. She has served on the National Advisory Council of AHRQ, National Executive Council of the American Diabetes Association, National Council of the Society of General Internal Medicine, and International Board of Directors for Physicians for Human Rights. She is a consultant to CME Outfitters, where she provides health equity education to health providers. Dr. Peek received her M.D. from Johns Hopkins University School of Medicine, completed her residency at Stanford University Hospital, and received her M.P.H. from Johns Hopkins University School of Hygiene & Public Health and M.Sc. from the University of Chicago. Dr. Peek was a planning committee member of the National Academies workshop series on Evolving Crisis Standards of Care and Lessons from COVID-19 and is a member of NAM.

Brian Rivers, Ph.D., M.P.H., is the director of the Cancer Health Equity Institute and professor of community health and preventative medicine at the Morehouse School of Medicine. Dr. Rivers is nationally and internationally recognized as a thought leader in health disparities research. He has endeavored to expand the application of population-based intervention science to address cancer health disparities in clinical and community-based settings, using multilevel, multidomain, and multisectoral approaches, such as novel technological platforms and iterations of the Patient Navigation model. Dr. Rivers has presented his novel and innovative research findings in diverse settings, including the First Congress on Oncology Clinical Trials (Lagos, Nigeria), Movember International Prostate Cancer Consortium (Queensland, Australia), The Atlantic, The People vs. Cancer, South by Southwest conferences, and National Press Foundation. Dr. Rivers is an active member in the American Association for Cancer Research (AACR) community and serves in several leadership capacities, such as on the steering committee for its inaugural Cancer Disparities Progress Report, chair for its Minorities in Cancer Research Council, cochair for its 11th Conference on Cancer Health Disparities and its Think Tank on Cancer Health Disparities, and the National Advisory Committee for the Robert A. Winn Diversity in Clinical Trials Award Program established by Bristol Myers Squibb, Virginia Commonwealth University, AACR, and Gilead Sciences. Dr. Rivers is also cochair for the Georgia Cancer Control Consortium, a state-funded entity responsible for developing the state’s cancer plan and maintaining the cancer prevention and control infrastructure. Dr. Rivers is a retired member of the National Advisory Council on Minority Health and Health Disparities of the National Institutes of Health. He holds a Ph.D. in health behaviors from the University of Alabama at Birmingham School of Public Health, M.P.H. in social and behavioral sciences from the Morehouse School of Medicine, and a B.S. in biology from Vanderbilt University.

Sara Rosenbaum, J.D., is professor emerita of health law and policy at the Milken Institute School of Public Health, George Washington University, where she held the Harold and Jane Hirsh Professorship and served as founding chair of the Department of Health Policy. She has devoted her career to advancing the health of medically underserved populations; she developed numerous amicus briefs and written extensively on topics ranging from women’s health to Medicaid participation and health equity and disparities. She has served on numerous governmental and other committees, including the CDC director’s advisory committee and CDC advisory committee on immunization practice. She was appointed by Congress as a founding commissioner of the Medicaid and CHIP Payment and Access

Commission, which she chaired January 2016–April 2017. Professor Rosenbaum is the recipient of many honors and awards, including the NAM Adam Yarmolinsky Medal, APHA Executive Director Award for Service, Association of Schools and Programs of Public Health Welch-Rose Award for Lifetime Contributions to the Health of the Public, and GW’s Trachtenberg Prize for Research. She received her J.D. from Boston University Law School and B.A. in American studies from Wesleyan University. She is a member of NAM.

Ruth S. Shim, M.D., M.P.H., is the Luke & Grace Kim Professor in Cultural Psychiatry in the Department of Psychiatry and Behavioral Sciences at the University of California–Davis and associate dean of diverse and inclusive education at its School of Medicine. Dr. Shim is an expert on mental health equity, structural racism in medicine, and diversity, equity, and inclusion in academic medicine. She is coeditor of the books The Social Determinants of Mental Health and Social (In)Justice and Mental Health and serves on the editorial boards of Psychiatric Services, JAMA Psychiatry, Community Mental Health Journal, and American Psychiatric Publishing. She is a member of the board of trustees of the Robert Wood Johnson Foundation. She received an M.P.H. in health policy from Rollins School of Public Health at Emory University and an M.D. from Emory University School of Medicine. Dr. Shim is an at-large member of the National Academies Forum on Mental Health and Substance Use Disorders and was a member of the Committee on the Science of Changing Behavioral Health Social Norms.

Kosali I. Simon, Ph.D., is an economist and a distinguished professor and Herman Wells Professor at Indiana University, Bloomington, O’Neill School of Public and Environmental Affairs, where she is also an O’Neill Chair and the associate vice provost of health sciences. Dr. Simon studies impacts of state and federal health policies on health and related outcomes and disparities among at-risk populations and has spoken at conferences and other professional venues on the effects of federal and state policies on pharmaceutical and related markets. She has published research on racial equity and inequity in health care, specifically related to cancer treatment, opioid use disorder, and COVID-19. She is the editor of Journal of Health Economics and coeditor of Journal of Human Resources. Dr. Simon is a member of the U.S. Congressional Budget Office’s panel of health advisors and president-elect of the American Society of Health Economists. Dr. Simon received her Ph.D. in Economics from the University of Maryland. She serves on the National Academies Roundtable on Population Health Improvement. She is a member of NAM.

Paul C. Tang, M.D., M.S., is an adjunct professor in the Clinical Excellence Research Center at Stanford University and an internist at the Palo Alto Medical Foundation (PAMF). He was chief innovation and technology officer at PAMF and vice president and chief health transformation officer at IBM Watson Health. He has more than 25 years of executive leadership experience in health information technology within medical groups, health systems, and corporate settings. Dr. Tang was cochair of the federal Health Information Technology Policy committee, 2009–2017. He has served as board chair for several health informatics professional associations, including the American Medical Informatics Association. He received his B.S. and M.S. in electrical engineering from Stanford University and M.D. from the University of California—San Francisco. He has served on numerous National Academies committees and chaired the committee that produced the Patient Safety: A New Standard for Care and Key Capabilities of an Electronic Health Record System reports. He is a member of NAM.

Reginald Tucker-Seeley, Sc.D., is the principal and owner of Health Equity Strategies and Solutions, which is a supporting partner in developing, implementing, and evaluating grants and in project/programs focused on SDOH, financial hardship/financial toxicity related to chronic disease (especially cancer), health disparities measurement, and health equity strategy. He was the vice president of health equity at ZERO—The End of Prostate Cancer, where he led the development and implementation of its health equity strategy to reduce racial/ethnic and place-based disparities in prostate cancer. He was the inaugural Edward L. Schneider chair in gerontology and an assistant professor in the Leonard Davis School of Gerontology at the University of Southern California (USC). Before USC, he was an assistant professor of social and behavioral sciences at DFCI and HSPH. Dr. Tucker-Seeley’s research has focused on SDOH across the life course, such as the association between the neighborhood environment and health behavior, and individual-level socioeconomic determinants of multimorbidity, mortality, and self-rated physical, mental, and oral health. He has also investigated the association of financial hardship with health across the cancer continuum from prevention to end-of-life care. Dr. Tucker-Seeley has a long-standing interest in the impact of health policy and social policy on racial/ethnic minorities and across socioeconomic groups. He has experience working on local and state level health disparities policy and developed and taught courses focused on measuring and reporting health disparities. Dr. Tucker-Seeley was a Robert Wood Johnson Health Policy Fellow with a placement in the U.S. Senate. He serves as a board member at the American Board of Internal Medicine Foundation and National Patient Advocate Foundation and chair-elect of the Health Equity and Outcomes Committee of

the American Society of Clinical Oncology. Dr. Tucker-Seeley completed an M.A. and Sc.D. in public health (social and behavioral sciences) at the Harvard T.H. Chan School of Public Health (HSPH) and a postdoctoral fellowship in cancer prevention and control at HSPH and the Dana-Farber Cancer Institute. He cochaired the National Academies workshop planning committee on Promoting Health Equity in Cancer Care and is a member of the Roundtable on the Promotion of Health Equity.

Consuelo Hopkins Wilkins, M.D., M.Sc., is senior vice president and senior associate dean for health equity and inclusive excellence, Vanderbilt University Medical Center. Dr. Wilkins is a nationally recognized physician-scientist leader in health equity research focused on integrating social, cultural, and environmental factors into clinical and translational research. Throughout her career, Dr. Wilkins has led local and regional centers focused on eliminating systemic inequities that disproportionately impact racially and ethnically minoritized groups, including two NIH-funded centers addressing disparities in African Americans and Hispanic/Latino/a populations. She is a member of the American Society of Clinical Investigation. She received the prestigious Marion Spencer Fay Award. She earned a B.S. in microbiology and M.D. from Howard University. Dr. Wilkins completed internal medicine residency at Duke University Medical Center, geriatric medicine fellowship at Washington University School of Medicine/Barnes-Jewish Hospital, and an M.Sc. in clinical investigation from Washington University School of Medicine. Dr. Wilkins is a member of NAM.

BOARD ON POPULATION HEALTH AND PUBLIC HEALTH PRACTICE LIAISON

Joshua Salomon, Ph.D., is a professor of Health Policy at Stanford University School of Medicine, associate chair for faculty affairs and strategy in the department of health policy, and senior fellow at the Freeman Spogli Institute for International Studies. His research focuses on public health policy and priority-setting to enhance the evidence base for reasoned decision making that improves population health and reduces disparities. He conducts policy modeling and program evaluation within three main substantive areas: (1) modeling and forecasting patterns and trends in major causes of global mortality and disease burden, (2) comparative assessment of public health and health care interventions and strategies, and (3) measurement and valuation of health outcomes. Dr. Salomon is director of the Prevention Policy Modeling Lab, a multi-institution research consortium that conducts health and economic modeling relating to infectious disease. Before Stanford, Dr. Salomon was professor of Global Health at HSPH; he served as a policy analyst at the World Health Organization. He is a member of the National Academies Board on Population Health and Public Health Practice.

NASEM PROJECT STAFF

Francis Amankwah, M.P.H., is an HMD senior program officer. He has managed consensus study committees and guided them in consensus building and also been the responsible staff officer for numerous workshops and convening activities. Among his recent work are the workshops on Innovation in Electronic Health Records for Oncology Care, Research, and Surveillance, Promoting Health Equity in Cancer Care, Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic Care, and Suicide Prevention in Indigenous Communities. He was the responsible staff officer on the National Academies congressionally mandated study that produced the consensus report Medications in Single-Dose Vials: Implications of Discarded Drugs. He also played an integral role in developing the National Academies consensus reports Guiding Cancer Control: A Path to Transformation and Making Medicines Affordable: A National Imperative. He received the HMD Veteran, Mount Everest, and Fineberg staff achievement awards. He earned his M.P.H. and a graduate certificate in global planning and international development from Virginia Tech. He was raised in Ghana, West Africa, where he earned his B.S. in agricultural science from Kwame Nkrumah University of Science and Technology.

Chidinma Chukwurah, B.S., is a senior program assistant with the National Academies Board on Health Care Services. She provides administrative support for the National Cancer Policy Forum and other workshops and convening activities within the board. The recent workshops she has supported include Addressing Resistance to Immune Modulator Therapies for Cancer Treatment and The Potential Contribution of Cancer Geonomics Information to Community Investigations of Unusual Patterns of Cancer. She was born and raised in Washington, DC. She earned her B.S. in health policy and administration from Penn State University.

Amira Daoud, M.A., is an HMD research associate on the Board of Health Care Services. Earlier, they were a research assistant at the Baylor College of Medicine’s Center for Medical Ethics and Health Policy. At Baylor, they specialized in the ethical, legal, and social implications of genomic and neurological research. They are a bioethicist whose research interests focus on health equity, eliminating health disparities, sexual and gender minorities (SGM), and minority communities’ health, health care, and ethics. They obtained their M.A. in bioethics from New York University, where they wrote their master’s thesis on the philosophical implications of a right to adequate health care for SGM people of color. They obtained their B.A. in philosophy with a pre-health concentration from New York University.

Rose Marie Martinez, Sc.D., is senior board director of the National Academies Board on Population Health and Public Health Practice. The board has a vibrant portfolio of studies that address high-profile and pressing issues that affect population health; it considers the science base for population health and public health interventions and examines the capacity of the health system, particularly the public health infrastructure, to support disease prevention and health promotion activities, including educating and supplying health professionals necessary for carrying them out. The board has examined such topics as the safety of childhood vaccines and other drugs, systems for evaluating and ensuring drug safety postmarketing, pandemic influenza planning, the health effects of cannabis and cannabinoids, the health effect of environmental exposures, the integration of medical care and public health, women’s health services, health disparities, health literacy, tobacco control strategies, and chronic disease prevention. Earlier, Dr. Martinez was a senior health researcher at Mathematica Policy Research, where she investigated the impact of health system change on the public health infrastructure, access to care for low-income populations, managed care, and the health care workforce. Dr. Martinez is a former assistant director for health financing and policy with the U.S. General Accounting Office, where she directed evaluations and policy analysis in national and public health issues. She also spent 6 years directing research studies for the Regional Health Ministry of Madrid, Spain. Dr. Martinez received a D.Sc. from the Johns Hopkins School of Hygiene and Public Health.

Sharyl J. Nass, Ph.D., serves as senior director of the Board on Health Care Services and director of the National Cancer Policy Forum at the National Academies. To enable the best possible care for all patients, the board undertakes scholarly analysis of the organization, financing, effectiveness, workforce, and delivery of health care, with emphasis on quality, cost, and accessibility. The forum examines policy issues pertaining to the entire continuum of cancer research and care. For more than 2 decades, Dr. Nass has worked on a broad range of health and science policy topics that includes the quality, safety, and equity of health care and clinical trials, developing technologies for precision medicine, and strategies to support clinician wellbeing. She has a Ph.D. from Georgetown University and postdoctoral training at the Johns Hopkins University School of Medicine and undertook a research fellowship at the Max Planck Institute in Germany. She also holds a B.S. and an M.S. from the University of Wisconsin–Madison. She has been the recipient of the Cecil Medal for Excellence in Health Policy Research, a Distinguished Service Award from the National Academies, and the Institute of Medicine staff team achievement award (as team leader).

FELLOWS AND CONSULTANTS

Alicia Cohen, M.D., MSc, FAAFP, is a practicing family physician and health services researcher. She is an investigator at the VA Center of Innovation in Long Term Services and Supports and an assistant professor of family medicine and health services, policy, and practice at the Brown University Alpert Medical School and School of Public Health. Her research aims to understand and improve patient, community, health system, and structural-level processes to identify and address adverse SDOH and advance health equity. She has published extensively on SDOH and social care integration, food insecurity, and health disparities, and her work has been cited in congressional testimony on veteran and military hunger. She serves on the VA Health Equity Coalition and the Government Affairs & Public Policy Committee for the national antihunger nonprofit MAZON. Dr. Cohen earned her M.D. from the Icahn School of Medicine at Mount Sinai and completed family medicine residency at UCSF–Santa Rosa. She was a Robert Wood Johnson Foundation Clinical Scholar at the University of Michigan, during which time she earned her M.Sc. in Health and Health Care Research. She is a 2022–2024 James C. Puffer/American Board of Family Medicine Fellow with NAM and a 2022–2025 VA fellow on the National Academies Roundtable on the Promotion of Health Equity.

Tracy Madsen, M.D., Ph.D., FAHA, FACEP, is a 2021 NAM fellow in emergency medicine. Dr. Madsen is an associate professor of emergency medicine and epidemiology at Brown University, the vice-chair of research in the Department of Emergency Medicine, and interim director of the Division of Sex and Gender in Emergency Medicine. She has expertise in sex- and gender-based medicine, acute cerebrovascular disease, stroke epidemiology and prevention, and disparities in the health care system and the emergency medicine workforce. Dr. Madsen’s research is funded by the National Heart, Lung, and Blood Institute. She has more than 100 peer-reviewed publications and speaks nationally and internationally on topics including stroke in women, health inequities in stroke, and disparities in the academic emergency medicine workforce. She is regarded as an expert in stroke in women. She completed an M.A. in clinical and translational research and a Ph.D. in epidemiology, both at the Brown University School of Public Health. Dr. Madsen received her M.D. from the Boston University School of Medicine and completed a residency (and was chief resident in her last year) at Brown before completing a research fellowship in the Division of Sex and Gender Medicine.

This page intentionally left blank.